Revelation Biosciences
REVB
5 hedge funds and large institutions have $759K invested in Revelation Biosciences in 2023 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, reducing their positions, and 4 closing their positions.
0.02% less ownership
Funds ownership: 0.02% → 0% (-0.02%)
28% less capital invested
Capital invested by funds: $1.05M → $759K (-$289K)
29% less funds holding
Funds holding: 7 → 5 (-2)
50% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$188K |
| 2 |
Walleye Capital
New York
|
+$150K |
| 3 |
VF
Virtu Financial
New York
|
+$75.2K |
| 4 |
HF
HRT Financial
New York
|
+$18.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AFM
Anson Funds Management
Dallas,
Texas
|
-$278K |
| 2 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$142K |
| 3 |
ACM
Altium Capital Management
New York
|
-$48.4K |
| 4 |
CH
CVI Holdings
Wilmington,
Delaware
|
-$43.2K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$1.77K |
REVB Hedge Fund Activity: Q2 2023 in Review
5 institutional investors reported a position in Revelation Biosciences (REVB) for Q2 2023, worth a combined $759K — down 28% from $1.05M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of REVB and 2 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 2 added.
The largest buyer was Sabby Management, adding an estimated $188K. The largest seller was Anson Funds Management, exiting entirely with an estimated $278K sold.
- 5 institutional investors held Revelation Biosciences (REVB) as of Q2 2023, down from 7 in Q1 2023.
- Funds reported $759K of Revelation Biosciences stock for Q2 2023, down 28% quarter-over-quarter.
- 2 funds opened new Revelation Biosciences positions in Q2 2023 and 4 closed out, a net change of -2 holders.
- The largest Revelation Biosciences buyer in Q2 2023 was Sabby Management, an estimated $188K added.
- The largest Revelation Biosciences seller in Q2 2023 was Anson Funds Management, an estimated $278K sold.
Based on aggregated 13F filings for Q2 2023.